reports
Lombard Medical Reports First Half and Third Quarter 2017 Financial Re...
OXFORDSHIRE, U.K.--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today reported unaudited year-to-date financial results for the first nine months ended September 30, 2017. 2017 Operational Highlights Appointment of Kurt Lemvigh as CEO, April 2017 Appointment of Richard Peace as Finance Director, May 2017 Appointment of Jonathan Hornsby as Vice President, Sales & Marke...
Lombard Medical Announces Shares to Trade on OTCQX
OXFORDSHIRE, U.K.--(BUSINESS WIRE)-- Lombard Medical, Inc. (Nasdaq: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today announced that it has notified Nasdaq of its intention to voluntarily delist the Company’s shares from the Nasdaq Capital Market (“Nasdaq”) and transfer its listing to the OTCQX. Lombard anticipates that its common shares will trade under its existing ticker symbol EVAR on the OTCQX Market effective as of the market open on November 9, 2017. ...
Lombard Medical Announces First Patient Enrolled and Treated in the AL...
OXFORDSHIRE, U.K.--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that it has enrolled and treated the first patient in its global registry to evaluate its Altura® Endograft System. The ALTITUDE registry (ALTura Impact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design) is being conducted across a range of UK and international clinical centers to evaluate the use of the Altura Endograf...
Lombard Medical’s Endovascular Product Portfolio Presented at Scient...
OXFORDSHIRE, U.K.--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the 39th annual Charing Cross International Symposium in London on April 25 - 26. Altura Presentations Altura clinical data combined from two prospective international multicentre studies were presented at Charing Cross i...
Lombard Medical Appoints New CEO
OXFORDSHIRE, England--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lemvigh is a veteran medical device executive with over 30 years of experience creating profitable growth. He currently resides in the U.K. and has held senior sales, marketing and operational positions at various public and private companies including ...
Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Resul...
OXFORDSHIRE, U.K.--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, today reported financial results for the fourth quarter and year ended December 31, 2016. Recent Operational Highlights The signing of a strategic partnership with MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices. Highlights of the partnership ...
Lombard Medical’s CEO Steps Down
OXFORDSHIRE, England--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a successor and an announcement is expected in due course. Hubbert joined Lombard during 2010 and was appointed CEO in 2011. During Hubbert’s tenure, Lombard achieved several significant milestones, ...
Lombard Medical and MicroPort Scientific Corporation Finalize Strategi...
OXFORDSHIRE, U.K. & SHANGHAI--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have finalized the definitive agreements to their strategic partnership first announced on December 19, 2016. The partnership will allow Lombard to accelerate commercialization in China and other global markets f...
Lombard Medical Announces Successful Completion of First 15 Cases in J...
OXFORDSHIRE, England--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that physicians in Japan have successfully treated the first 15 patients using its innovative new IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft since launch on February 1, 2017. Aorfix with IntelliFlex is exclusively distributed in Japan by Medico’s Hirata Inc., one of the country’s leading supplier...
Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex...
OXFORDSHIRE, England--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex™ Low Profile (LP) Delivery System for the Aorfix™ Endovascular Stent Graft. Commercial launch will follow reimbursement approval, which is anticipated in February 2017. Aorfix with IntelliFlex is exclusively distributed by Medico's Hirata In...
Lombard Medical and MicroPort Scientific Corporation Announce Strategi...
OXFORDSHIRE, England & SHANGHAI--(BUSINESS WIRE)-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced a strategic partnership and a significant infusion of capital into Lombard Medical by MicroPort. This partnership will allow Lombard Medical to accelerate commercialization in key global markets with its two key products: Aorfix™,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.